142 related articles for article (PubMed ID: 30342344)
1. Dynamic and significant changes of T-cell subgroups in breast cancer patients during surgery and chemotherapy.
Wang WH; Xu HY; Zhao ZM; Zhang GM; Lin FW
Int Immunopharmacol; 2018 Dec; 65():279-283. PubMed ID: 30342344
[TBL] [Abstract][Full Text] [Related]
2. CD8-positive memory T cells in tumor-draining lymph nodes of patients with breast cancer.
Vahidi Y; Bagheri M; Ghaderi A; Faghih Z
BMC Cancer; 2020 Mar; 20(1):257. PubMed ID: 32228503
[TBL] [Abstract][Full Text] [Related]
3. The peripheral blood leukocyte phenotype in patients with breast cancer: effect of doxorubicin/paclitaxel combination chemotherapy.
Melichar B; Tousková M; Dvorák J; Jandík P; Kopecký O
Immunopharmacol Immunotoxicol; 2001 May; 23(2):163-73. PubMed ID: 11417845
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte subpopulations in patients with advanced breast cancer submitted to neoadjuvant chemotherapy.
Murta EF; de Andrade JM; Falcão RP; Bighetti S
Tumori; 2000; 86(5):403-7. PubMed ID: 11130570
[TBL] [Abstract][Full Text] [Related]
5. Elevated level of peripheral CD8(+)CD28(-) T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy.
Song G; Wang X; Jia J; Yuan Y; Wan F; Zhou X; Yang H; Ren J; Gu J; Lyerly HK
Cancer Immunol Immunother; 2013 Jun; 62(6):1123-30. PubMed ID: 23604172
[TBL] [Abstract][Full Text] [Related]
6. Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes.
Faghih Z; Erfani N; Haghshenas MR; Safaei A; Talei AR; Ghaderi A
Immunol Lett; 2014; 158(1-2):57-65. PubMed ID: 24326038
[TBL] [Abstract][Full Text] [Related]
7. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast.
Rathore AS; Kumar S; Konwar R; Makker A; Negi MP; Goel MM
Indian J Med Res; 2014 Sep; 140(3):361-9. PubMed ID: 25366203
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotypic characterization of CD45RO+ and CD45RA+ T cell subsets in peripheral blood of peripheral T cell lymphoma patients.
Yang W; Jia X; Su Y; Li Q
Cell Biochem Biophys; 2014 Nov; 70(2):993-7. PubMed ID: 24840225
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood T lymphocyte subsets in children with congenital asplenia.
Motkowski R; Michalkiewicz J; Mikoluc B; Smolka-Afifi D; Pietrucha B; Kubiszewska I; Piotrowska-Jastrzebska J; Bernatowska E
Hum Immunol; 2012 Nov; 73(11):1091-7. PubMed ID: 22902394
[TBL] [Abstract][Full Text] [Related]
10. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast.
Leong PP; Mohammad R; Ibrahim N; Ithnin H; Abdullah M; Davis WC; Seow HF
Immunol Lett; 2006 Feb; 102(2):229-36. PubMed ID: 16246429
[TBL] [Abstract][Full Text] [Related]
11. CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer.
Okita R; Saeki T; Takashima S; Yamaguchi Y; Toge T
Oncol Rep; 2005 Nov; 14(5):1269-73. PubMed ID: 16211295
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of T lymphocyte subset changes after first line chemotherapy in peripheral blood from patients with advanced stage adenocarcinoma cell lung cancer].
Yan X; Zhao X; Jiao S; Sun S; Wu L; Wu Z
Zhongguo Fei Ai Za Zhi; 2012 Mar; 15(3):164-71. PubMed ID: 22429580
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of changes in percentage of phenotype CD4 + CD45RA + and CD4+ CD45RO + in peripheral blood and effect of immunomodulation in aged male patients with chronic cardiac insufficiency].
Han LN; Lin XM; Li J; Zang CB; Yang LM; Ding GL; Peng J
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Sep; 29(5):416-21. PubMed ID: 24386816
[TBL] [Abstract][Full Text] [Related]
15. Abnormalities in the T and NK lymphocyte phenotype in patients with Nijmegen breakage syndrome.
Michałkiewicz J; Barth C; Chrzanowska K; Gregorek H; Syczewska M; Weemaes CM; Madaliński K; Stachowski J;
Clin Exp Immunol; 2003 Dec; 134(3):482-90. PubMed ID: 14632755
[TBL] [Abstract][Full Text] [Related]
16. [CD4+CD25+T regulatory cells in peripheral blood of B-NHL patients with or without chemotherapy].
Shi YX; Zhang XS; Liu DG; Li YQ; Guan ZZ; Jiang WQ
Ai Zheng; 2004 May; 23(5):597-601. PubMed ID: 15142463
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation and function of tumor-infiltrating T cells in different stages of breast cancer patients.
Zhu S; Lin J; Qiao G; Xu Y; Zou H
Tumour Biol; 2015 Sep; 36(10):7907-13. PubMed ID: 25953262
[TBL] [Abstract][Full Text] [Related]
18. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
[TBL] [Abstract][Full Text] [Related]
19. GITR-expressing regulatory T-cell subsets are increased in tumor-positive lymph nodes from advanced breast cancer patients as compared to tumor-negative lymph nodes.
Krausz LT; Fischer-Fodor E; Major ZZ; Fetica B
Int J Immunopathol Pharmacol; 2012; 25(1):59-66. PubMed ID: 22507318
[TBL] [Abstract][Full Text] [Related]
20. Changes in cellular immunity during chemotherapy for primary breast cancer with anthracycline regimens.
Wijayahadi N; Haron MR; Stanslas J; Yusuf Z
J Chemother; 2007 Dec; 19(6):716-23. PubMed ID: 18230556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
